Your browser doesn't support javascript.
loading
The Risk of Prostate Cancer Progression in Active Surveillance Patients with Bilateral Disease Detected by Combined Magnetic Resonance Imaging-Fusion and Systematic Biopsy.
Williams, Cheyenne; Khondakar, Nabila R; Daneshvar, Michael A; O'Connor, Luke P; Gomella, Patrick T; Mehralivand, Sherif; Yerram, Nitin K; Egan, Jillian; Gurram, Sandeep; Rompré-Brodeur, Alexis; Webster, Bradley R; Owens-Walton, Jeunice; Parnes, Howard; Merino, Maria J; Wood, Bradford J; Choyke, Peter; Turkbey, Baris; Pinto, Peter A.
Afiliación
  • Williams C; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Khondakar NR; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Daneshvar MA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • O'Connor LP; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Gomella PT; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mehralivand S; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yerram NK; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Egan J; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Rompré-Brodeur A; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Webster BR; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Owens-Walton J; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Parnes H; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Merino MJ; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Wood BJ; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Choyke P; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
J Urol ; 206(5): 1157-1165, 2021 11.
Article en En | MEDLINE | ID: mdl-34181465
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article